Forte Biosciences, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Forte Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Forte Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -151 %, a 70.2% decline year-over-year.
  • Forte Biosciences, Inc. annual Return On Equity for 2023 was -94.3 %, a 172% decline from 2022.
  • Forte Biosciences, Inc. annual Return On Equity for 2022 was -34.7 %, a 24.1% increase from 2021.
  • Forte Biosciences, Inc. annual Return On Equity for 2021 was -45.8 %, a 76% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -94.3 -59.6 -172% Jan 1, 2023 Dec 31, 2023
2022 -34.7 +11 +24.1% Jan 1, 2022 Dec 31, 2022
2021 -45.8 +145 +76% Jan 1, 2021 Dec 31, 2021
2020 -191 -321 -246% Jan 1, 2020 Dec 31, 2020
2019 131 +259 Jan 1, 2019 Dec 31, 2019
2018 -128 +17.5 +12% Jan 1, 2018 Dec 31, 2018
2017 -146 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.